However, transgenic KO of WNK3, abridged ischemia-mediated SPAK/OSR1-NKCC1 phosphorylation and displayed reduced cerebral edema, axonal demyelination, and infarct volume, as well as improved post-stroke neurological recovery when compared to WT mice [32]. This evidence concerns the gene WNK3 and stroke disorder.